Anti-GPC3 CAR-T for Treating GPC3-positive Advanced Hepatocellular Carcinoma (HCC)

NCT03084380 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

BIOLOGICAL: Retroviral vector-transduced autologous T cells to express anti-GPC3 CARs
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Xinqiao Hospital of Chongqing